Sitemap
Pages
Posts
News
- Vox.Bio Awarded as Top Consulting Company 2024 by MedTech Outlook
- Vox.Bio Senior Research Executive, Gaia Ferracci PhD, wins EPHMRA’s 2023 Young Professional Grant
- No more box-ticking: the rise of digitalisation will finally put patients front and centre
- Looking Back To Look Forward – What can we learn from looking at failed innovation from digital leaders in big tech
- Webinar: The role of the patient influencer in the future of healthcare
- The future of digital health in healthcare
- Vox.Bio to exhibit at Med-Tech 2023
- Assessing social data as real-world data: its benefits, its risks, its future
- Vox.Bio to host: The role of the patient influencer in the future of healthcare (Webinar)
- Advice from a patient influencer
- How can different methodologies work together to uncover richer patient insights?
- What’s the hype about patient influencers?
- The rise of mHealth in sub-Saharan Africa: A more affordable and accessible healthcare future
- Ask The Expert – An Interview with Stephen Godwin
- Vox.Bio exhibiting at Pharma Market Research Conference (PMRC)
- Five steps to succeeding with suppliers
- Data analytics: Using your data to its full potential
- Vox @ EPHMRA: How to find the edge in strategic innovation
- Vox @ BHBIA 22: Evolution of the NHS
- Advanced Analytics: Understanding stakeholder preferences through conjoint analysis
- Healthcare Market Research and Pharma CI: Two Parts of the Same Whole
- Cambridge Healthcare Research appoints Head of Operations Rich McLean, formerly Head of European Operations at Amazon
- Leveraging Patient Journey Mapping
- Interview with Senior Research Executive, Beth Ayerst
- CHR for Society shares new logo and branding, making a more impactful presence with their Corporate Social Responsibility framework
- Vox.Bio and CHR welcomes Steve Scott as new Head of Finance
- Re-think Your Next RfP: The Benefits of Real-world Approaches in Healthcare Market Research
- Part II-Should Your Strategy be a Destination or a Journey
- Part I-Should Your Strategy Be A Destination Or A Journey?
- Unlocking the Opportunity in Axial Spondyloarthritis – Treating the Visible and the Invisible
- Keep Looking: Beyond Market Research Methodologies
- Supporting Young Minds
- Has COVID-19 Indefinitely Disrupted the Pharma Sales Model?
- The Gene Therapy Revolution Has Arrived. But What’s Next?
- Is the US Finally Ready for the Biosimilar Boom?
- Managing cancer patients during the COVID-19 pandemic
- Welcome to our new CEO Chris Stevenson
- COVID-19 Dissecting the Therapeutic and Vaccine Landscape
- Mindfulness Event
- We are working from home
- Keep Calm and Carry on Researching
- Will PSMA-targeting diagnostics and therapeutics revolutionize Prostate Cancer care?
- Can Digital Health Fundamentally Change Healthcare in APAC?
- ‘tis the Season for Giving
- Rapid Approvals & Innovative Approaches, But Which Sickle Cell Therapies Will Offer Real Benefits?
- We have launched our new London Office!
- Key Insights from ESMO 2019
- Why focus groups can give you more…
- Findacure Rare Disease Showcase
- BIO Asia Taiwan 2019 Highlights
- Celebrating Five Years
- Is the era of PowerPoint over?
- Empowering patients with pick and mix management tools
- BHBIA Conference 2019
- How We Use Secondary Landscape Analysis to Build Confidence in Our Research Insights
- Can Consumer Technology Really Improve Long Term Health Outcomes?
- Why the First 10 Minutes of Qualitative Research are so Important
- A Quick Guide to MaxDiff
- Happy Holidays!!
- Market Research with Oncology Patients
- UEGW Highlights
- Everything you need to know about the use of Conjoint in Health Market Research
- How does switching to biosimilars effect patients?
- CAR-T Therapies and the Challenge of Pricing Research
- Summer Social
- The Rise of Orals
- There is a Right and a Wrong Way to do KOL Research
- Complementary Therapies in Breast Cancer
- ASCO Highlights
- The Research Ripple Effect
- Digital Health in Respiratory Care
Projects
- Tracking T1D Needs, Attitudes & Perceptions to Inform Portfolio Strategy
- A deep-dive into the pulmonary embolism care pathway to inform our client’s future device strategy
- Utilising a multi-phase approach to support development of innovative concepts for the respiratory home care market
- Integrating MR and CI insights to uncover PIs’ perceptions of trial designs and drivers of trial decision-making
- Combining competitive insights alongside market research to find the optimal execution strategy for clinical trials
- A holistic assessment of the drivers and barriers to proceeding with bariatric surgery
- Mapping the BPM healthcare landscape in four key African markets to shape internal market strategy
- Utilising an online community to evaluate and refine key promotional materials for a newly acquired asset